On 4 September 2026, IndexBox published a market outlook naming South Korea, alongside China, Taiwan and Japan, as a leading consumption centre and a significant production base for coagulation-aid surfactant compounds used in wastewater treatment, with the Asia-Pacific region accounting for roughly 50–55% of world demand by volume IndexBox. The report projects global demand for these compounds to grow at a compound annual rate of 5–7% through 2035, with the market index rising from a base of 100 in 2025 to approximately 170 by 2035 IndexBox. Electronics and semiconductor manufacturing, an estimated 18–25% of global consumption, is identified as the fastest-growing end-use segment, a vertical where South Korean fabs and printed-circuit-board plants are major buyers IndexBox.
Key takeaways
- IndexBox, on 4 September 2026, projects 5–7% global CAGR for coagulation-aid surfactant compounds through 2035 IndexBox.
- The same report says Asia-Pacific, including South Korea, accounts for roughly 50–55% of world demand by volume IndexBox.
- Electronics and semiconductor fabs represent an estimated 18–25% of global consumption, the report's fastest-growing end-use segment IndexBox.
- MarketsandMarkets valued the broader Asia-Pacific wastewater treatment services market at $27,311.9 million in 2025, projected to reach $39,676.4 million by 2030 at a 7.75% CAGR MarketsandMarkets.
- The IndexBox outlook says ZLD and water-reuse mandates in semiconductor fabs are reducing chemical consumption and sludge handling costs by an estimated 10–20% per treatment cycle IndexBox.
What happened
A South Korea-anchored Asia-Pacific demand story
The IndexBox outlook, published on 4 September 2026, frames South Korea as part of a four-country Asia-Pacific core that combines consumption of high-purity coagulation aids with local production IndexBox. The report says the region "also exhibits the highest import dependence for high-purity and specialty-grade compounds, creating opportunities for formulators with advanced product portfolios" IndexBox. Within that, South Korea's role is tied to semiconductor fabs, printed-circuit-board plants and precision-component cleaning operations, where wastewater streams carry high loads of surfactants, metals and organic solvents from etching and cleaning steps IndexBox.
Figures and what is driving the segment
The IndexBox report ties the South Korea demand pull to three forces: tighter chemical oxygen demand, heavy-metal and emerging-contaminant discharge limits; zero-liquid-discharge and water-reuse mandates inside fabs; and a procurement shift toward low-foaming and biodegradable surfactant formulations IndexBox. It estimates that improved flocculation efficiency at lower dosages is reducing chemical consumption and sludge handling costs by an estimated 10–20% per treatment cycle IndexBox. The report also flags feedstock price volatility for ethoxylated alcohols, alkylphenols and quaternary ammonium compounds, which it says represent 55–70% of finished product cost IndexBox.
Broader regional context and supply chain
Separately, MarketsandMarkets, in a report published 18 August 2026, valued the Asia-Pacific wastewater treatment services market at $27,311.9 million in 2025 and projected $39,676.4 million by 2030, a 7.75% CAGR that the firm notes exceeds the global average of 6.78% MarketsandMarkets. A third outlet, Fortune Business Insights, has a membrane-bioreactor market page at the URL below, but the page returned a security-check screen when accessed, so no figures from that source could be verified Fortune Business Insights. IndexBox adds that mid-sized chemical formulators are establishing blending and distribution hubs in Vietnam, Malaysia and India to serve the relocating electronics assembly base, a shift that IndexBox expects to reduce reliance on China-centric production IndexBox. Representative participants named in the IndexBox outlook include Kurita Water Industries Ltd, Ecolab Inc, Solenis LLC, ChemTreat Inc and BASF SE IndexBox.
Specification read
The IndexBox report does not break out a contract value, plant capacity in m³/day, or a population equivalent for the South Korea coagulation-aid segment, so no project-scale figure can be reported from the sources. For context only, a single mid-sized semiconductor fab wet-processing line typically generates on the order of 5,000–20,000 m³/day of process wastewater before reclaim, with influent COD in the several-hundred to low-thousand mg/L range, a class range that would call for a treatment train of screening and equalisation, DAF or primary clarification for emulsified surfactant and metal break-up, biological treatment such as A2O or MBR for organics, and tertiary polishing with RO and ZLD evaporation or crystallisation where discharge permits require near-zero effluent; this paragraph is a general industry range, not from the sources. If your plant is a South Korean semiconductor or PCB facility handling 1,000–20,000 m³/day of surfactant- and metal-laden wastewater under tightening COD and heavy-metal permits and a water-reuse or ZLD mandate, the reported 5–7% global CAGR and 10–20% per-cycle chemical-and-sludge savings on high-purity, low-foaming biodegradable coagulant aids are the procurement signals to plan around (general industry range, not from the sources). For product-side context on the biological and membrane stages that typically follow coagulation in this class of plant, see Mbr Membrane Systems and Chemical, and for related site-level selection guidance, see DAF vs Clarifier for Mining Wastewater in South Holland, US: 2026 Factory Guide.
FAQ
What is driving coagulation-aid surfactant demand in South Korea through 2035?
IndexBox, on 4 September 2026, attributes the demand to tightening COD, heavy-metal and emerging-contaminant discharge limits, plus water-reuse and ZLD mandates in semiconductor fabs IndexBox. The same report projects a 5–7% global CAGR for the segment through 2035 IndexBox.
How much could lower-dosage, high-purity coagulant aids cut chemical and sludge costs?
IndexBox estimates chemical consumption and sludge handling costs can fall by an estimated 10–20% per treatment cycle when flocculation efficiency improves at lower dosages under ZLD and reuse mandates IndexBox. Actual savings at a given South Korean fab will depend on influent matrix and dosing strategy; that is a general industry range, not from the sources.
Which suppliers are named in the IndexBox outlook for this segment?
IndexBox names Kurita Water Industries Ltd, Ecolab Inc, Solenis LLC, ChemTreat Inc and BASF SE as representative participants IndexBox. Procurement teams in South Korea should qualify these and local formulators against the report's 6–18 month qualification window for new products IndexBox.
How does the broader Asia-Pacific services market size compare to this chemistry outlook?
MarketsandMarkets, in a report published 18 August 2026, valued Asia-Pacific wastewater treatment services at $27,311.9 million in 2025 and projects $39,676.4 million by 2030 at a 7.75% CAGR, above the global 6.78% MarketsandMarkets. That figure covers services, not just coagulation-aid chemistry, so it is a context line, not a direct spend estimate for South Korean fabs.
